English version
Tore Haslemo

Tore Haslemo


Vitenskapelige publikasjoner

Hole, Kristine ; Lorentsen, Silje K; Nordby, Karoline L; Slettvik, Marie; Sørum, Ida TG; Molden, Espen; Haslemo, Tore (2024). Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets. European Journal of Clinical Pharmacology.

Hole, Kristine ; Gangsø, Sofie; Jensstuen, Åse Tonette; Ormøy, Hanne Holte; Paulsen, Maren; Molden, Espen; Haslemo, Tore (2023). Effect of CYP2D6 genotype on duloxetine serum concentration. Basic & Clinical Pharmacology & Toxicology. Vol. 134.

Hole, Kristine ; Haslemo, Tore ; Molden, Espen (2023). Impact of CYP2D6 Genotype on Paroxetine Serum Concentration. 5 s. Therapeutic Drug Monitoring. Vol. 45.

Solhaug, Vigdis; Haslemo, Tore ; Kringen, Marianne Kristiansen ; Molden, Espen; Dietrichs, Erik Sveberg (2022). Genotyping av pasienter behandlet med selektive serotoninreopptakshemmere. 9 s. Tidsskrift for Den norske legeforening. Vol. 142.

Bråten, Line Skute; Haslemo, Tore ; Jukić, Marin M.; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K. (2021). A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram. Clinical Pharmacology and Therapeutics. Vol. 110.

Tveito, Marit; Høiseth, Gudrun; Haslemo, Tore ; Molden, Espen; Smith, Robert Løvsletten (2021). Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients. European Journal of Clinical Pharmacology. Vol. 77.

Hole, Kristine ; Arnestad, Marianne; Molden, Espen; Haslemo, Tore (2021). Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients with Depression. 4 s. Journal of Clinical Psychopharmacology. Vol. 41.

Kringen, Marianne K. ; Bråten, Line Skute; Haslemo, Tore ; Molden, Espen (2020). The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O -Desmethylvenlafaxine Concentrations in a Large Patient Cohort. 7 s. Journal of Clinical Psychopharmacology. Vol. 40.

Smith, Robert Løvsletten; Kyllesø, Lennart; Haslemo, Tore ; Andreassen, Ole Andreas; Molden, Espen (2019). Reduction in N-desmethylclozapine level is determined by daily dose but not serum concentration of valproic acid-indications of a presystemic interaction mechanism. Therapeutic Drug Monitoring. Vol. 41.

Jukic, Marin M.; Smith, Robert Løvsletten; Haslemo, Tore ; Molden, Espen; Ingelman-Sundberg, Magnus (2019). Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study. The Lancet Psychiatry. Vol. 6.

Publikasjonslisten er hentet ut av Cristin. Listen kan være ufullstendig